JWCA
AGN

J.W. Cole Advisors’s Allergan plc AGN Stock Holding History

J.W. Cole Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,764
Closed -$312K – 323
2020
Q1 		$312K Sell
1,764
-1,138
-39% -$214K 0.6% 50
2019
Q4 		$555K Buy
+2,902
New +$524K 0.07% 285

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

J.W. Cole Advisors's AGN Position: Q2 2020 in Review

J.W. Cole Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,764 shares — an estimated $312K sold.

J.W. Cole Advisors first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $555K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • J.W. Cole Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • J.W. Cole Advisors sold 1,764 Allergan plc shares in Q2 2020, an estimated $312K.
  • J.W. Cole Advisors first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • J.W. Cole Advisors's Allergan plc position peaked at $555K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on J.W. Cole Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.